Heisz Leslie Stone - Feb 13, 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: Director
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Feb 13, 2025
Transactions value $: -$175,298
Form type: 4
Date filed: 2/13/2025, 06:04 PM
Previous filing: Oct 23, 2024
Next filing: May 9, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$260K	+5.74K	+19.11%	$45.32	35.8K	Feb 13, 2025	Direct
transaction	EW	Common Stock	Sale	-$435K	-5.74K	-16.04%	$75.86	30K	Feb 13, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Director Stock Option (Right to Acquire)	Options Exercise	$0	-5.74K	-100%	$0.00	0	Feb 13, 2025	Common Stock	5.74K	$45.32	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $75.42 to $76.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.